Your browser doesn't support javascript.
loading
Clinical Heart fAilure Management Program: Changing the practice by partnering primary care and specialists (CHAMP-HF).
Parent, Marianne; Leclerc, Jacinthe; O'Meara, Eileen; Barrette, Réal; Lévesque, Sylvie; Parent, Marie-Claude; Brouillette, Denis; Garceau, Patrick; Liszkowski, Mark; Rouleau, Jean; Ducharme, Anique.
Afiliação
  • Parent M; Faculty of Medicine, University of Montreal, Montreal, Canada.
  • Leclerc J; Department of Medicine, Montreal Heart Institute, Montreal, Canada.
  • O'Meara E; Faculty of Pharmacy, Université Laval, Quebec, Canada.
  • Barrette R; Research Center, Quebec Heart and Lung Institute, Université Laval, Quebec, Canada.
  • Lévesque S; Faculty of Medicine, University of Montreal, Montreal, Canada.
  • Parent MC; Department of Medicine, Montreal Heart Institute, Montreal, Canada.
  • Brouillette D; GMF-R Centre Médical Hochelaga, Montréal, Canada.
  • Garceau P; Montreal Health Innovation Coordinating Center, Biostatistics, Montreal, Canada.
  • Liszkowski M; Faculty of Medicine, University of Montreal, Montreal, Canada.
  • Rouleau J; Department of Medicine, Montreal Heart Institute, Montreal, Canada.
  • Ducharme A; Department of Pharmacy, Montreal Heart Institute, Montreal, Canada.
Int J Cardiol Heart Vasc ; 50: 101330, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38298468
ABSTRACT

Background:

While significant gains were made in the management of heart failure (HF), most patients are still diagnosed when they are acutely ill in hospital, often with advanced disease. Earlier diagnosis in the community could lead to improved outcomes. Whether a partnership and an educational program for primary care providers (PCP) increase HF awareness and management is unknown.

Methods:

We conducted an observational study between March 2019 and June 2020 during which HF specialists gave monthly HF conferences to PCP. Using a pre-post design, medical charts and administrative databases were reviewed and a questionnaire was completed by participating PCP. Primary and secondary endpoints included 1) the number of patients diagnosed with HF, 2) implementation of GDMT for patients with HFrEF; 3) PCPs' experience and confidence.

Results:

Six PCP agreed to participate. Amongst the 11,909 patients of the clinic, 70 (0.59 %) patients met the criteria for HF. This number increased by 28.6 % (n = 90) after intervention. Increased use of GDMT for HFrEF patients at baseline (n = 35) was observed for all class of agents, with doubling of patients on triple therapies, from 8 (22.9 %) to 16 (45.7 %), p = 0.0047. Self-confidence on HF management was low (1, 16.7 %) but increased after the educational intervention of physicians (3, 50 %).

Conclusion:

An educational and collaborative approach between HF specialists and community PCP increased the number of new HF cases diagnosed, enhanced implementation of GDMT in patients with HFrEF and increase PCPs' confidence in treating HF, despite being conducted during the COVID-19 pandemic.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article